Annual Operating Expenses:
$150.57M+$50.04M(+49.77%)Summary
- As of today, VKTX annual total operating expenses is $150.57 million, with the most recent change of +$50.04 million (+49.77%) on December 31, 2024.
- During the last 3 years, VKTX annual operating expenses has risen by +$95.19 million (+171.86%).
- VKTX annual operating expenses is now at all-time high.
Performance
VKTX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$98.45M+$23.98M(+32.21%)Summary
- As of today, VKTX quarterly total operating expenses is $98.45 million, with the most recent change of +$23.98 million (+32.21%) on September 30, 2025.
- Over the past year, VKTX quarterly operating expenses has increased by +$61.98 million (+169.95%).
- VKTX quarterly operating expenses is now at all-time high.
Performance
VKTX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VKTX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +49.8% | +169.9% |
| 3Y3 Years | +171.9% | +513.2% |
| 5Y5 Years | +364.4% | +907.3% |
VKTX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +171.9% | at high | +513.2% |
| 5Y | 5-Year | at high | +364.4% | at high | +907.3% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
VKTX Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $98.45M(+32.2%) |
| Jun 2025 | - | $74.46M(+34.5%) |
| Mar 2025 | - | $55.36M(+20.0%) |
| Dec 2024 | $150.57M(+49.8%) | $46.13M(+26.5%) |
| Sep 2024 | - | $36.47M(+7.3%) |
| Jun 2024 | - | $33.98M(-0.1%) |
| Mar 2024 | - | $34.00M(+16.4%) |
| Dec 2023 | $100.53M(+43.5%) | $29.21M(+7.4%) |
| Sep 2023 | - | $27.19M(+14.9%) |
| Jun 2023 | - | $23.67M(+15.6%) |
| Mar 2023 | - | $20.46M(+1.3%) |
| Dec 2022 | $70.06M(+26.5%) | $20.21M(+25.9%) |
| Sep 2022 | - | $16.05M(-8.9%) |
| Jun 2022 | - | $17.63M(+9.0%) |
| Mar 2022 | - | $16.17M(+30.0%) |
| Dec 2021 | $55.39M(+30.7%) | $12.43M(-6.7%) |
| Sep 2021 | - | $13.33M(-13.8%) |
| Jun 2021 | - | $15.47M(+9.3%) |
| Mar 2021 | - | $14.16M(+26.5%) |
| Dec 2020 | $42.38M(+30.7%) | $11.19M(+14.5%) |
| Sep 2020 | - | $9.77M(-7.3%) |
| Jun 2020 | - | $10.54M(-3.1%) |
| Mar 2020 | - | $10.88M(+22.6%) |
| Dec 2019 | $32.43M | $8.87M(+19.3%) |
| Sep 2019 | - | $7.44M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $9.57M(+40.6%) |
| Mar 2019 | - | $6.81M(-3.3%) |
| Dec 2018 | $26.16M(+37.2%) | $7.04M(-4.8%) |
| Sep 2018 | - | $7.39M(+6.8%) |
| Jun 2018 | - | $6.92M(+44.1%) |
| Mar 2018 | - | $4.80M(+8.5%) |
| Dec 2017 | $19.07M(+37.7%) | $4.43M(-5.6%) |
| Sep 2017 | - | $4.69M(-5.8%) |
| Jun 2017 | - | $4.98M(+0.3%) |
| Mar 2017 | - | $4.97M(+32.9%) |
| Dec 2016 | $13.85M(+15.4%) | $3.74M(+14.5%) |
| Sep 2016 | - | $3.26M(-8.8%) |
| Jun 2016 | - | $3.58M(+9.5%) |
| Mar 2016 | - | $3.27M(-29.3%) |
| Dec 2015 | $12.00M(-48.9%) | $4.62M(+7.7%) |
| Sep 2015 | - | $4.29M(+63.2%) |
| Jun 2015 | - | $2.63M(+469.8%) |
| Mar 2015 | - | $461.00K(-97.9%) |
| Dec 2014 | $23.47M(>+9900.0%) | - |
| Jun 2014 | - | $21.76M(>+9900.0%) |
| Mar 2014 | - | $131.50K(+673.5%) |
| Dec 2013 | $101.10K(-7.8%) | - |
| Jun 2013 | - | $17.00K(+431.3%) |
| Mar 2013 | - | $3200.00(-97.1%) |
| Dec 2012 | $109.60K | $109.60K |
FAQ
- What is Viking Therapeutics, Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Viking Therapeutics, Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Viking Therapeutics, Inc.?
- What is Viking Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Viking Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of VKTX is $150.57M
What is the all-time high annual operating expenses for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high annual total operating expenses is $150.57M
What is Viking Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, VKTX annual total operating expenses has changed by +$50.04M (+49.77%)
What is Viking Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of VKTX is $98.45M
What is the all-time high quarterly operating expenses for Viking Therapeutics, Inc.?
Viking Therapeutics, Inc. all-time high quarterly total operating expenses is $98.45M
What is Viking Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, VKTX quarterly total operating expenses has changed by +$61.98M (+169.95%)